Chinese Visceral Adipose Index Shows Superior Diagnostic Performance in Predicting the Risk of Metabolic Dysfunction Associated Fatty Liver Disease in Early Postmenopausal Chinese Women

References

• Younossi ZM, Koenig AB, Abdelatif D, et al. Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes. Hepatology. 2016;64:73–84. doi:10.1002/hep.28431
   PubMed Web of Science ®Google Scholar
• European Association for the Study of the Liver (EASL), European Association for the Study of Diabetes (EASD), European Association for the Study of Obesity (EASO). EASL-EASD-EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease. J Hepatol. 2016;64(6):1388–1402. doi:10.1016/j.jhep.2015.11.004
   PubMed Web of Science ®Google Scholar
• Pouwels S, Sakran N, Graham Y, et al. Non-alcoholic fatty liver disease (NAFLD): a review of pathophysiology, clinical management and effects of weight loss. BMC Endocr Disord. 2022;22:63.
   PubMed Web of Science ®Google Scholar
• Eslam M, Sarin SK, Wong VW, et al. The Asian Pacific Association for the Study of the Liver clinical practice guidelines for the diagnosis and management of metabolic associated fatty liver disease. Hepatol Int. 2020;14(6):889–919. doi:10.1007/s12072-020-10094-2
   PubMed Web of Science ®Google Scholar
• Eslam M, Sanyal AJ, George J. MAFLD: a consensus-driven proposed nomenclature for metabolic associated fatty liver disease. Gastroenterology. 2020;158(7):1999–2014. doi:10.1053/j.gastro.2019.11.312
   PubMed Web of Science ®Google Scholar
• Davis T. Diabetes and metabolic dysfunction-associated fatty liver disease. Metabolism. 2021;123:154868. doi:10.1016/j.metabol.2021.154868
   PubMed Web of Science ®Google Scholar
• Eslam M, Newsome PN, Sarin SK, et al. A new definition for metabolic dysfunction-associated fatty liver disease: an international expert consensus statement. J Hepatol. 2020;73(1):202–209. doi:10.1016/j.jhep.2020.03.039
   PubMed Web of Science ®Google Scholar
• Yamamura S, Eslam M, Kawaguchi T, et al. MAFLD identifies patients with significant hepatic fibrosis better than NAFLDJ. Liver Int. 2020;40(12):3018–3030. doi:10.1111/liv.14675
   PubMed Web of Science ®Google Scholar
• Liu Q, Zhao G, Li Q, et al. A comparison of NAFLD and MAFLD diagnostic criteria in contemporary urban healthy adults in China: a cross-sectional study. BMC Gastroenterol. 2022;22(1):471. doi:10.1186/s12876-022-02576-4
   PubMed Web of Science ®Google Scholar
• Lin S, Huang J, Wang M, et al. Comparison of MAFLD and NAFLD diagnostic criteria in real world. Liver Int. 2020;40(9):2082–2089. doi:10.1111/liv.14548
   PubMed Web of Science ®Google Scholar
• Lin H, Zhang X, Li G, et al. Epidemiology and clinical outcomes of metabolic (dysfunction)-associated fatty liver disease. J Clin Transl Hepatol. 2021;9(6):972–982. doi:10.14218/JCTH.2021.00201
   PubMed Web of Science ®Google Scholar
• Li J, Zou B, Yeo YH, et al. Prevalence, incidence, and outcome of non-alcoholic fatty liver disease in Asia, 1999–2019: a systematic review and meta-analysis. Lancet Gastroenterol Hepatol. 2019;4(5):389–398. doi:10.1016/S2468-1253(19)30039-1
   PubMed Web of Science ®Google Scholar
• Estes C, Anstee QM, Arias-Loste MT, et al. Modeling NAFLD disease burden in China, France, Germany, Italy, Japan, Spain, United Kingdom, and United States for the period 2016–2030. J Hepatol. 2018;69(4):896–904. doi:10.1016/j.jhep.2018.05.036
   PubMed Web of Science ®Google Scholar
• Huh JH, Kim KJ, Kim SU, et al. Obesity is an important determinant of severity in newly defined metabolic dysfunction-associated fatty liver disease. Hepatobiliary Pancreat Dis Int. 2022;21(3):241–247. doi:10.1016/j.hbpd.2022.03.009
   PubMed Web of Science ®Google Scholar
• Kosekli MA, Kurtkulagii O, Kahveci G, et al. The association between serum uric acid to high density lipoprotein-cholesterol ratio and non-alcoholic fatty liver disease: the abund study. Rev Assoc Med Bras. 2021;67:549–554. doi:10.1590/1806-9282.20201005
   PubMed Web of Science ®Google Scholar
• Aktas G, Kocak MZ, Duman TT, et al. Mean Platelet Volume (MPV) as an inflammatory marker in type 2 diabetes mellitus and obesity. Bali Med J. 2018;7:3. doi:10.15562/bmj.v7i3.806
   Web of Science ®Google Scholar
• Kuk JL, Church TS, Blair SN, et al. Measurement site and the association between visceral and abdominal subcutaneous adipose tissue with metabolic risk in women. Obesity. 2010;18(7):1336–1340. doi:10.1038/oby.2009.414
   PubMed Web of Science ®Google Scholar
• Demerath EW, Reed D, Rogers N, et al. Visceral adiposity and its anatomical distribution as predictors of the metabolic syndrome and cardiometabolic risk factor levelsJ. Am J Clin Nutr. 2008;88(5):1263–1271. doi:10.3945/ajcn.2008.26546
   PubMed Web of Science ®Google Scholar
• Lee S, Kim KW, Lee J. Sex-specific Cutoff Values of Visceral Fat Area for Lean vs overweight/obese nonalcoholic fatty liver disease in Asians. J Clin Transl Hepatol. 2022;10(4):595–599. doi:10.14218/JCTH.2021.00379
   PubMed Web of Science ®Google Scholar
• Han M, Qin P, Li Q, et al. Chinese visceral adiposity index: a reliable indicator of visceral fat function associated with risk of type 2 diabetes. Diabetes Metab Res Rev. 2021;37(2):e3370. doi:10.1002/dmrr.3370
   PubMed Web of Science ®Google Scholar
• Xia MF, Lin HD, Chen LY, et al. Association of visceral adiposity and its longitudinal increase with the risk of diabetes in Chinese adults: a prospective cohort study. Diabetes Metab Res Rev. 2018;34(7):e3048. doi:10.1002/dmrr.3048
   PubMed Web of Science ®Google Scholar
• Kang SH, Cho Y, Jeong SW, et al. From nonalcoholic fatty liver disease to metabolic-associated fatty liver disease: big wave or ripple? Clin Mol Hepatol. 2021;27(2):257–269. doi:10.3350/cmh.2021.0067
   PubMed Web of Science ®Google Scholar
• Rajindrajith S, Pathmeswaran A, Jayasinghe C, et al. Non-alcoholic fatty liver disease and its associations among adolescents in an urban, Sri Lankan community. BMC Gastroenterol. 2017;17(1):135. doi:10.1186/s12876-017-0677-7
   PubMedGoogle Scholar
• Chen YL, Li H, Li S, et al. Prevalence of and risk factors for metabolic associated fatty liver disease in an urban population in China: a cross-sectional comparative study. BMC Gastroenterol. 2021;21(1):212. doi:10.1186/s12876-021-01782-w
   PubMed Web of Science ®Google Scholar
• Sheng G, Lu S, Xie Q, et al. The usefulness of obesity and lipid-related indices to predict the presence of Non-alcoholic fatty liver disease. Lipids Health Dis. 2021;20(1):134. doi:10.1186/s12944-021-01561-2
   PubMed Web of Science ®Google Scholar
• Castera L, Friedrich-Rust M, Loomba R. Noninvasive assessment of liver disease in patients with nonalcoholic fatty liver disease. Gastroenterology. 2019;156(5):1264–1281. doi:10.1053/j.gastro.2018.12.036
   PubMed Web of Science ®Google Scholar
• Khalfa A, Tiali A, Zemour L, et al. Prevalence of metabolic syndrome and its association with lifestyle and cardiovascular biomarkers among postmenopausal women in western Algeria. Int J Gynaecol Obstet. 2017;138(2):201–206. doi:10.1002/ijgo.12206
   PubMed Web of Science ®Google Scholar
• Almeida NS, Rocha R, Cotrim HP, et al. Anthropometric indicators of visceral adiposity as predictors of non-alcoholic fatty liver disease: a review. World J Hepatol. 2018;10(10):695–701. doi:10.4254/wjh.v10.i10.695
   PubMed Web of Science ®Google Scholar
• Younossi ZM. Non-alcoholic fatty liver disease - A global public health perspective. J Hepatol. 2019;70(3):531–544. doi:10.1016/j.jhep.2018.10.033
   PubMed Web of Science ®Google Scholar
• Cai J, Lin C, Lai S, et al. Waist-to-height ratio, an optimal anthropometric indicator for metabolic dysfunction associated fatty liver disease in the Western Chinese male population. Lipids Health Dis. 2021;20(1):145. doi:10.1186/s12944-021-01568-9
   PubMed Web of Science ®Google Scholar
• Agbim U, Carr RM, Pickett-Blakely O, et al. Ethnic disparities in adiposity: focus on non-alcoholic fatty liver disease, visceral, and generalized obesity. Curr Obes Rep. 2019;8(3):243–254. doi:10.1007/s13679-019-00349-x
   PubMed Web of Science ®Google Scholar
• Li B, Lai X, Yan C, et al. The associations between neutrophil-to-lymphocyte ratio and the Chinese Visceral Adiposity Index, and carotid atherosclerosis and atherosclerotic cardiovascular disease risk. Exp Gerontol. 2020;139:111019. doi:10.1016/j.exger.2020.111019
   PubMed Web of Science ®Google Scholar
• Li B, Wang J, Zhou X, et al. Chinese visceral adiposity index is more closely associated with hypertension and prehypertension than traditional adiposity indices in Chinese population: results from the REACTION Study. Front Endocrinol. 2022;13:921997. doi:10.3389/fendo.2022.921997
   PubMed Web of Science ®Google Scholar
• Pan L, Xu Q, Liu J, et al. Dose-response relationship between Chinese visceral adiposity index and type 2 diabetes mellitus among middle-aged and elderly Chinese. Front Endocrinol. 2022;13:959860. doi:10.3389/fendo.2022.959860
   PubMed Web of Science ®Google Scholar
• Shang L, Li R, Zhao Y, et al. Association between Chinese visceral adiposity index and incident type 2 diabetes mellitus in Japanese adults. Diabetes Metab Syndr Obes. 2021;14:3743–3751. doi:10.2147/DMSO.S322935
   PubMed Web of Science ®Google Scholar
• Han M, Qie R, Li Q, et al. Chinese visceral adiposity index, a novel indicator of visceral obesity for assessing the risk of incident hypertension in a prospective cohort study. Br J Nutr. 2021;126(4):612–620. doi:10.1017/S0007114520004298
   PubMed Web of Science ®Google Scholar
• Masarone M, Rosato V, Dallio M, et al. Role of oxidative stress in pathophysiology of nonalcoholic fatty liver disease. Oxid Med Cell Longev. 2018;2018:9547613. doi:10.1155/2018/9547613
   PubMed Web of Science ®Google Scholar
• Theofilis P, Vordoni A, Nakas N, et al. Endothelial dysfunction in nonalcoholic fatty liver disease: a systematic review and meta-analysis. Life. 2022;12:5. doi:10.3390/life12050718
   Google Scholar
• Lu Y, Yang H, Xu Z, et al. Association between different obesity patterns and the risk of developing type 2 diabetes mellitus among adults in Eastern China: a cross-sectional study. Diabetes Metab Syndr Obes. 2021;14:2631–2639. doi:10.2147/DMSO.S309400
   PubMed Web of Science ®Google Scholar
• Camporez JP, Lyu K, Goldberg EL, et al. Anti-inflammatory effects of oestrogen mediate the sexual dimorphic response to lipid-induced insulin resistance. J Physiol. 2019;597(15):3885–3903. doi:10.1113/JP277270
   PubMed Web of Science ®Google Scholar
• Nickelson KJ, Stromsdorfer KL, Pickering RT, et al. A comparison of inflammatory and oxidative stress markers in adipose tissue from weight-matched obese male and female mice. Exp Diabetes Res. 2012;2012:859395. doi:10.1155/2012/859395
   PubMedGoogle Scholar
• Koutsari C, Basu R, Rizza RA, et al. Nonoxidative free fatty acid disposal is greater in young women than men. J Clin Endocrinol Metab. 2011;96(2):541–547. doi:10.1210/jc.2010-1651
   PubMed Web of Science ®Google Scholar
• Lewis GF, Uffelman KD, Szeto LW, et al. Interaction between free fatty acids and insulin in the acute control of very low density lipoprotein production in humans. J Clin Invest. 1995;95(1):158–166. doi:10.1172/JCI117633
   PubMed Web of Science ®Google Scholar